Taxotere Hair Loss lawsuits in settlement discussion. According to sources, the Taxotere hair loss lawsuits may be in preliminary stages of settlement talks. The judge overseeing the multidistrict litigation in the Taxotere chemotherapy drug products liability litigation has ordered plaintiff attorneys to file information about all pending and anticipated claims…
Cancer patients receiving chemotherapy understand there is a risk of hair loss involved. In fact, along with nausea, hair loss is the most common and well known side effect of cancer drugs. Cancer paitents tolerate hair loss as a side effect because of the hope that the drug will save…
A lawsuit filed in California alleges that the makers of a popular chemotherapy drug misrepresented the drug’s benefits and hid side effects, including permanent hair loss. Breast cancer survivor Ami Dodson filed a lawsuit against the makers of Taxotere (docetaxel) claiming the drug caused her to suffer permanent hair loss…
Nearly 75 percent of women in the United States with breast cancer have been prescribed Taxotere as part of chemotherapy. Medical professionals are now taking a second look at the drug after reports suggests that it might lead to permanent hair loss. According to a lawsuit filed by Ami Dodson,…
Although hair loss is a common side effect of chemotherapy, permanent hair loss is not. However, as lawsuits against the makers of Taxotere are beginning to reveal, that is not always the situation. The FDA approved Taxotere (docetaxel) in 1996 for treatment of breast cancer. Taxotere has since been used…